Is non-surgical spinal decompression a scam?

Short answer: no — but a lot of the advertising for it is. The most-cited criticism of non-surgical spinal decompression, an NBC News investigation from 2020, is that clinics advertise 86-92% success rates that trace back to manufacturer marketing rather than real-world evidence. That criticism is substantially correct, and the peer-reviewed evidence base is genuinely thin — the trials are small and much of the research is manufacturer-adjacent. So we did the obvious thing: we reviewed 1,377 of our own patient charts and published the result, including the patients it did not help. Our strict response rate is 62% (95% CI 58-67%, n=426) — lower than the numbers the industry advertises.

What the critics actually say

The parties Google cites for this question — NBC News (2020) and Science-Based Medicine — make a specific charge, and it is worth stating fairly: the advertised success rates are marketing figures, not real-world outcomes; the treatment is expensive; and most insurers classify it as experimental. Daniel DM (2007) asked the question directly in the title of his paper — does the scientific literature support the efficacy claims made in the advertising media? — and answered that it largely did not.

We are not going to argue with any of that. It is the reason this page exists.

Where they are right

• The advertised rates are marketing. The 86-92% figures floated across this industry trace to manufacturer materials, not to independent outcomes.
• The cost is real and it is usually out of pocket. Many insurers treat decompression as experimental.
• The published evidence is thin. The trials are small and a good share of them are tied to device makers.

Conceding all of that is not a weakness in the case for the treatment. It is the only honest place to start.

Where the criticism has a gap

Here is the one thing the critics could not check: at the time of the NBC piece, no clinic had published real-world outcomes at any scale. The largest previously published real-world series was on the order of a few hundred patients. We reviewed 1,377 charts spanning 2005 to 2026 — our own patients, on our own DRX9000 — and published what we found.

So here is ours

Among patients who completed a full 12-to-24-session course and started with meaningful pain of at least 4 out of 10:

• 62% had a clinically meaningful reduction in pain at their final visit (95% CI 58-67%, n=426).
• 38% did not meet that threshold.
• The worst-case floor is 34%. Count every patient who ever started a course — everyone who quit early or whose records were incomplete — as a failure, and the response rate is 34% (n=975). We publish that number beside the 62%.

Our headline number is lower than the figures the industry advertises. That should increase your confidence, not lower it — a clinic willing to publish a number below its competitors’ marketing is showing you the real one.

The number we could have published instead

Under an older, looser measure — counting the best score a patient reached at any point rather than their final score — the same 426 patients give 85% (with the same worst-case floor of 48% under that looser measure). We publish the 62%. We are showing you the friendlier number specifically so you can see the one we chose not to use.

Is it worth the money?

That depends on your case, the course you actually need, and what you would otherwise spend on it. We do not post a fake flat price. The entry point is a $47 exam — consultation, X-rays, exam, and a Report of Findings — after which you get a real number for your situation. See cost and insurance for the full picture, and does spinal decompression work? for the outcomes in detail.

Who it is not for, and when not to book at all

Some spines should not be pulled, and some symptoms mean you need evaluation today rather than a course of care. If you have cauda-equina signs (a change in bladder or bowel control, saddle numbness), a neurological deficit that is getting worse, new or spreading weakness, or a suspected fracture, tumour or infection, do not book with us — be evaluated promptly. Patients who have had a spinal fusion respond least well in our data (39%, 95% CI 20-61%, n=18 — a small sample, so treat it as directional): fusion is harder, not hopeless, and we will tell you which you are.

We won’t take your case unless we’re confident decompression can help you. Dr. Frye reads your films herself — an MRI is not required.

Book the $47 exam · Call (661) 949-9655

Frequently asked questions

Is non-surgical spinal decompression a scam? No, but much of the advertising is. The commonly advertised 86-92% success rates trace to manufacturer marketing. We published our own 1,377-chart review instead: 62% of course completers with meaningful starting pain had a clinically meaningful reduction in pain (95% CI 58-67%, n=426), with a 34% worst-case floor across everyone who started (n=975).

Is the DRX9000 FDA approved? No device in this category is “FDA approved.” The DRX9000 is FDA 510(k) cleared, meaning it was found substantially equivalent to devices already legally marketed for the same use. Clinics that say “FDA approved” have it wrong.

Is it just traction? It is a targeted, computer-controlled form of traction built to ramp the pull past the muscle-guarding reflex that limits older traction and inversion tables. See the DRX9000.

Why doesn’t insurance cover it? Many insurers classify decompression as experimental, so patients often pay out of pocket. Some plans reimburse a portion. We verify your specific benefits before you commit.

Does it work long term? We do not have structured long-term follow-up — once a patient finishes their course, our records stop — so we make no durability claim, and neither honestly can anyone else publishing decompression outcomes.

Related: Does spinal decompression work? · Results and methods · The DRX9000 · Cost & insurance · Who decompression does not help · Dr. Suzanne Frye, DC · Home